
INVEGA (Paliperidone)
INVEGA is an atypical antipsychotic agent indicated for Treatment of schizophrenia (1.1) Adults: Efficacy was established in three 6-week trials and one maintenance trial. (14.1)…
INVEGA is an atypical antipsychotic agent indicated for Treatment of schizophrenia (1.1) Adults: Efficacy was established in three 6-week trials and one maintenance trial. (14.1)…
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for. Treatment of schizophrenia (1.1) Adults: Efficacy was established in three 6-week trials and…
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for. Treatment of schizophrenia (1.1). Adults: Efficacy was established in three 6-week trials and one…
INVEGA HAFYERA, an every-six-month injection, is indicated for the treatment of schizophrenia in adults after they have been adequately treated with: A once-a-month paliperidone palmitate…
39 mg 78 mg 117mg 156mg 234mg.
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2023. All Rights Reserved.